Global Oncology Academy

Cancer and Strategies for Fertility Preservation

Cancer and Strategies for Fertility Preservation
RestartResume
World population prospects were presented at the United Nations in 2013 and addressed directly global fertility projections. Fertility rates for ma...
  • Overview

    World population prospects were presented at the United Nations in 2013 and addressed directly global fertility projections. Fertility rates for many developed countries continue to decline and are projected to do so for the foreseeable future. As part of updating of the WHO Global Guidelines for infertility diagnosis, management and interventions for treatment initiated in January 2012, Guideline Development Groups were assembled. These focus on female subfertility; male subfertility, ovarian stimulation for ART, IVF and ICSI, IUI with and without ovarian stimulation, polycystic ovary syndrome (PCOS); endometriosis, fertility interventions; and environmental effects on fertility, with the call to enhance fertility awareness at the country, if not regional, level.1,2 

    Substantial educational and practice needs have been identified demonstrating how poor understanding of myriad causes of female infertility by clinicians results in their failure to appropriately consider the full value offered to affected women through assisted reproductive technologies (ARTs).

    This module addresses for the participant fertility preservation strategies for males with cancer; risk factors for ovarian failure in patients with cancer; options for fertility preservation in women, including women with breast cancer; and discusses the emergence of experimental fertility options.

  • Learning Objectives

    At the completion of this module, participants will be better able to:

    1. Articulate the epidemiology of male and female cancers, and risk factors for treatment-related gonadal and ovarian failure
    2. Discuss options for fertility preservation in males and females with cancer
    3. Safeguard fertility in adults at risk, and consider the suitability of experimental options available for both adults and children
    4. Assess the value of psychological evaluations in patients considering/not considering fertility preservation
  • Commercial Support

    This activity is supported by an independent educational grant from Merck KGaA, Darmstadt, Germany.
     
    Original Release Date: 13 January 2015
    Expiration Date: 21 January 2017

  • Disclosure of Conflicts of Interest

    COURSE DIRECTOR

    Pasquale Patrizio, MD, MBE, HCLD
    Professor Obstetrics and Gynecology 
    Director, Yale Fertility Center
    Yale University
    New Haven, CT
    Financial Relationship Disclosure
    Advisor: EMD Serono

    AUTHOR

    Pasquale Patrizio, MD, MBE, HCLD
    Professor Obstetrics and Gynecology 
    Director, Yale Fertility Center
    Yale University
    New Haven, CT
    Financial Relationship Disclosure
    Advisor: EMD Serono

    REVIEWER

    Michael J. Tucker, PhD, FIBiol, HCLD
    IVF Laboratory Director
    Shady Grove Fertility RSC
    Rockville, MD
    Financial Relationship Disclosure
    No relationship reported

Facebook Comments

Sign up for the Global Oncology Academy newsletters.
Comprehensive Oncology Education.

Better education for a better you.

* Required
Optional

NEW FEATURES:

Register

We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free